Diabetic foot ulcers (DFUs) are among the most severe late-stage complications in patients with diabetes. It is characterized by complex pathogenic factors, challenging treatments, and high rates of disability and mortality. Therefore, DFUs have become a major therapeutic challenge for patients with diabetes. In recent years, extracorporeal shock wave therapy (ESWT) has emerged as a novel modality for promoting the healing of both acute and chronic superficial wounds. An increasing number of studies have demonstrated significant clinical efficacy in the treatment of DFUs. Developed by experts from the Wound Repair Committee of the Chinese Medical Doctor Association through an extensive review of high-quality literature, this consensus systematically outlines the indications, contraindications, standardized procedures, key technical points, post-treatment patient management and assessment, and prevention and management of potential complications related to ESWT for DFUs. This consensus aims to provide clinical guidance and a practical reference for physicians in wound repair departments to apply ESWT in the management of diabetic foot ulcers.
19 December 2025 in Biochemical and Biophysical Research Communications
To elucidate the mechanisms underlying macrophage-mediated inflammation and tissue injury in diabetic foot ulcers (DFU). Skin tissue samples were collected from patients with diabetic foot ulcers and with non-ulcer diabetic foot (NDFU). A total of 79 272 high-quality cell transcriptomes were obtained using single-cell RNA sequencing. An unbiased clustering approach was employed to identify cell subpopulations. Systematic comparative analyses between the DFU and NDFU groups were conducted, including Gene Ontology (GO) enrichment analysis and screening of differentially expressed genes. Furthermore, cell-cell communication network construction and ligand-receptor interaction analysis were integrated to reveal the mechanisms underlying cellular interactions and signaling regulation in the DFU microenvironment from multiple perspectives. The results revealed a significant expansion of myeloid cells in DFU tissues, alongside a marked reduction in structural cells such as endothelial cells, epithelial cells, and smooth muscle cells. Major cell types underwent functional reprogramming, characterized by immune activation and impaired tissue remodeling. Specifically, macrophages in DFU tissues exhibited a shift toward a pro-inflammatory M1 phenotype, with upregulation of genes associated with inflammation and oxidative stress. Cell communication analysis further demonstrated that M1 macrophages act as both primary signal receivers and influencers in the COMPLEMENT pathway, and as key signal senders and regulators in the SPP1 pathway, actively shaping the inflammatory microenvironment. Key ligand-receptor interactions driving macrophage signaling were identified, including C3-(ITGAM+ITGB2) and SPP1-CD44. This study establishes a comprehensive single-cell atlas of DFU, revealing the role of macrophage-driven cellular networks in chronic inflammation and impaired healing. These findings may offer potential novel therapeutic targets for DFU treatment.
Background Premature ovarian insufficiency (POI) is often iatrogenic and the therapeutic potential of human umbilical cord derived mesenchymal stem cells (hUCMSCs) remain incompletely defined. This study aimed to evaluate the effects and underlying mechanism of hUCMSCs on ovarian function in a rat model of POI. Methods hUCMSCs were characterized by morphology, flow cytometry, and multi-lineage differentiation assays. POI was induced in rats using cyclophosphamide (CTX), followed by intravenous administration of hUCMSCs. Therapeutic outcomes were assessed through cell homing analysis, ovarian histopathology, and serum hormone measurements. Bioinformatic analysis identified Angiopoietin 1 (Angpt1) as a key angiogenic regulator, which was validated by western blot and qRT-PCR. Rat ovarian microvascular endothelial cells (ROMECs) were isolated and functionally assessed under CTX and hUCMSCs treatment using wound healing, tube formation, and evaluation of the Angpt1 and Angpt2 balance. Results In vivo, hUCMSCs preferentially homed to the ovarian theca layer and restored ovarian function. The Angpt1/ Angpt2 ratio was markedly reduced in POI rats but significantly increased after hUCMSCs treatment, and the ratio positively correlated with CD31 expression. In vitro, CTX impaired ROMECs migration and angiogenic capacity, whereas coculture with hUCMSCs rescued these functions and restored the Angpt1/Angpt2 ratio. Conclusion hUCMSCs ameliorate ovarian dysfunction in POI by modulating the Angpt1/Angpt2 axis, thereby enhancing vascular homeostasis and angiogenesis within the ovarian microenvironment. These findings provided mechanistic insights supporting the clinical translation of hUCMSCs-based therapies for POI.
Diabetic foot ulcer (DFU) is one of the most severe complications of diabetes, characterized by high rates of morbidity, disability, and mortality. Current treatment modalities for DFU primarily include surgical debridement, negative‐pressure wound therapy, and anti‐infection measures. However, these approaches are limited by prolonged treatment duration, high costs, and suboptimal therapeutic outcomes. Adipose‐derived mesenchymal stem cells (ADMSCs) have garnered significant attention in wound repair and tissue regeneration due to their ability to secrete a variety of cytokines involved in the healing process. Exosomes, as key mediators of the paracrine effects underlying the therapeutic benefits of ADMSCs, are emerging as promising agents for wound repair. As a novel therapeutic strategy, exosomes have been increasingly investigated for the treatment of DFU. In this review, we summarize the applications and therapeutic potential of ADMSC‐exosomes in DFU, aiming to provide a valuable reference for its clinical management.